Related references
Note: Only part of the references are listed.Radiomics signature of brain metastasis: prediction of EGFR mutation status
Guangyu Wang et al.
EUROPEAN RADIOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma
Xiran Jiang et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2021)
Subregional radiomics analysis for the detection of the EGFR mutation on thoracic spinal metastases from lung cancer
Ying Fan et al.
PHYSICS IN MEDICINE AND BIOLOGY (2021)
Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer
Bihong T. Chen et al.
FRONTIERS IN ONCOLOGY (2021)
Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas
Sushant Kumar Das et al.
SCIENTIFIC REPORTS (2021)
Lung microbiome alterations in NSCLC patients
Leliang Zheng et al.
SCIENTIFIC REPORTS (2021)
Radiomics in hepatic metastasis by colorectal cancer
Vincenza Granata et al.
INFECTIOUS AGENTS AND CANCER (2021)
Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study
Myeong Geun Choi et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectives
Sara Elena Rebuzzi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study
Lecia Sequist et al.
LANCET ONCOLOGY (2020)
Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS
Gil Pinheiro et al.
SCIENTIFIC REPORTS (2020)
MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer
Hayeong Park et al.
EUROPEAN RADIOLOGY (2020)
Radiomics in liver diseases: Current progress and future opportunities
Jingwei Wei et al.
LIVER INTERNATIONAL (2020)
Non-invasive decision support for NSCLC treatment using PET/CT radiomics
Wei Mu et al.
NATURE COMMUNICATIONS (2020)
Radiomics of Liver Metastases: A Systematic Review
Francesco Fiz et al.
CANCERS (2020)
3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma
Guixue Liu et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review
Yijia Guo et al.
FRONTIERS IN ONCOLOGY (2020)
Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology
Wenting Tu et al.
LUNG CANCER (2019)
CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma
Tong-xu Shen et al.
CANCER IMAGING (2019)
Additional local consolidative therapy has survival benefit over EGFR tyrosine kinase inhibitors alone in bone oligometastatic lung adenocarcinoma patients
Fang Hu et al.
LUNG CANCER (2019)
Predictive Power of a Radiomic Signature Based on 18F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
Xiaofeng Li et al.
FRONTIERS IN ONCOLOGY (2019)
Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning
Shuo Wang et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
Subba R. Digumarthy et al.
MEDICINE (2019)
The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges
Zhenyu Liu et al.
THERANOSTICS (2019)
A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy
Jiangdian Song et al.
CLINICAL CANCER RESEARCH (2018)
Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer
Liwen Zhang et al.
TRANSLATIONAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC
Tai H. Dou et al.
PLOS ONE (2018)
CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
Dongdong Mei et al.
CANCER IMAGING (2018)
Lung adenocarcinoma: Assessment of epidermal growth factor receptor mutation status based on extended models of diffusion-weighted image
Mei Yuan et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2017)
Radiological and Clinical Features associated with Epidermal Growth Factor Receptor Mutation Status of Exon 19 and 21 in Lung Adenocarcinoma
Zhang Shi et al.
SCIENTIFIC REPORTS (2017)
Computational Radiomics System to Decode the Radiographic Phenotype
Joost J. M. van Griethuysen et al.
CANCER RESEARCH (2017)
Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
Emmanuel Rios Velazquez et al.
CANCER RESEARCH (2017)
Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas
Ying Liu et al.
CLINICAL LUNG CANCER (2016)
Nomograms in oncology: more than meets the eye
Vinod P. Balachandran et al.
LANCET ONCOLOGY (2015)
Metastatic sites and survival in lung cancer
M. Riihimaeki et al.
LUNG CANCER (2014)
Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: A meta-analysis of randomized controlled clinical trials
Ning Zhao et al.
LUNG CANCER (2014)
Tumor microenviroment and hepatocellular carcinoma metastasis
Hongyang Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
N. Girard et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Gene Expression Profiling of Fixed Tissues Identified Hypoxia-Inducible Factor-1α, VEGF, and Matrix Metalloproteinase-2 as Biomarkers of Lymph Node Metastasis in Hepatocellular Carcinoma
Zuo-Lin Xiang et al.
CLINICAL CANCER RESEARCH (2011)
Outcomes After Combined Modality Therapy for EGFR-Mutant and Wild-Type Locally Advanced NSCLC
Raymond H. Mak et al.
ONCOLOGIST (2011)
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer A National Cancer Database Survey
Daniel Morgensztern et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge
F. van Zijl et al.
ONCOGENE (2009)
Selection of important variables and determination of functional form for continuous predictors in multivariable model building
Willi Sauerbrei et al.
STATISTICS IN MEDICINE (2007)
Texture analysis of medical images
G Castellano et al.
CLINICAL RADIOLOGY (2004)
Share Paper
